Copyright
THE death-knell may have been rung for Exclusive Marketing Rights (EMR) when the patent regime came into effect, in January 2005. But the ghosts of the past, it seems, can be exorcised only after the Patents (Amendment) Ordinance 2005 gets ratified in the coming Budget session of Parliament.
The first pharma company to get an EMR in India for its cancer drug, Novartis, has heard from the Indian Patent Office on the implementation of the Madras High Court order on giving the drug free to patients who cannot afford it. From the site
http://www.blonnet.com/2005/02/18/stories/2005021802450200.htm